MX9701477A - Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia. - Google Patents

Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia.

Info

Publication number
MX9701477A
MX9701477A MX9701477A MX9701477A MX9701477A MX 9701477 A MX9701477 A MX 9701477A MX 9701477 A MX9701477 A MX 9701477A MX 9701477 A MX9701477 A MX 9701477A MX 9701477 A MX9701477 A MX 9701477A
Authority
MX
Mexico
Prior art keywords
narcotic analgesic
alleviating pain
analgesia
enhancer
analgesia enhancer
Prior art date
Application number
MX9701477A
Other languages
English (en)
Inventor
David J Mayer
Donald D Price
Jianren Mao
John W Lyle
Original Assignee
Univ Virginia Commonwealth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia Commonwealth filed Critical Univ Virginia Commonwealth
Publication of MX9701477A publication Critical patent/MX9701477A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La eficacia analgésica de un analgésico no narcotico tal como NSAID o acetaminofen se mejora significativamente administrado el NSAID o el acetaminoften antes de, con o después de la administracion de un mejorador de analgia que es un bloqueador receptor de NMDA no toxico y/o una substancia no toxica que bloquea por lo menos una consecuencia intracelular principal de la activacion del receptor de NMDA.
MX9701477A 1994-09-02 1995-08-29 Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia. MX9701477A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30073694A 1994-09-02 1994-09-02
US38206395A 1995-02-01 1995-02-01
PCT/US1995/010994 WO1996007412A1 (en) 1994-09-02 1995-08-29 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer

Publications (1)

Publication Number Publication Date
MX9701477A true MX9701477A (es) 1998-02-28

Family

ID=26971951

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701477A MX9701477A (es) 1994-09-02 1995-08-29 Composicion para aliviar el dolor, que contiene un analgesico no narcotico y un mejorador de analgesia.

Country Status (21)

Country Link
EP (1) EP0778770B1 (es)
JP (1) JPH10505087A (es)
KR (1) KR970705390A (es)
CN (1) CN1213753C (es)
AT (1) ATE255895T1 (es)
AU (1) AU714653B2 (es)
BR (1) BR9508671A (es)
CA (1) CA2197463A1 (es)
CZ (1) CZ60697A3 (es)
DE (1) DE69532285T2 (es)
ES (1) ES2211916T3 (es)
FI (1) FI970865A (es)
HK (1) HK1006108A1 (es)
HU (1) HUT76798A (es)
MX (1) MX9701477A (es)
NO (1) NO970946L (es)
NZ (1) NZ292429A (es)
PL (1) PL319029A1 (es)
RU (1) RU2003115093A (es)
TW (1) TW449474B (es)
WO (1) WO1996007412A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
WO1997035584A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Method for treating pain
WO1998050075A1 (en) * 1997-05-07 1998-11-12 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
WO1998052540A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
WO1999008670A1 (en) 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
CA2296336C (en) 1997-09-08 2004-04-20 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
JP4562911B2 (ja) * 1998-01-13 2010-10-13 シンクロニュ−ロン，エルエルシ− 遅発性ジスキネジア及び他の運動障害の治療方法
US6054451A (en) * 1998-04-21 2000-04-25 Algos Pharmaceutical Corporation Analgesic composition and method for alleviating pain
JP2002538078A (ja) * 1998-11-12 2002-11-12 アルゴス ファーマシューティカル コーポレーション 痛みを治療するｎｍｄａ−ブロッカーと組み合わされたｃｏｘ−２阻害剤
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
DE102010024559A1 (de) 2010-06-22 2011-12-22 Süd-Chemie AG Verfahren zur Herstellung hydrophober Oberflächen
CN102266563A (zh) * 2011-07-13 2011-12-07 赵磊 一种复方止痛组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4446140A (en) * 1981-12-10 1984-05-01 Nelson Research & Development Company Method and composition for treating mouth pain
CA1194799A (en) * 1981-12-10 1985-10-08 Eric L. Nelson Method and composition for reducing menstrual pain
AU2062892A (en) * 1991-08-16 1993-02-18 Mcneil-Ppc, Inc. Potentiation of antitussive effect of dextromethorphan

Also Published As

Publication number Publication date
NZ292429A (en) 2000-01-28
BR9508671A (pt) 1998-01-06
ATE255895T1 (de) 2003-12-15
HUT76798A (en) 1997-11-28
PL319029A1 (en) 1997-07-21
AU714653B2 (en) 2000-01-06
EP0778770B1 (en) 2003-12-10
CA2197463A1 (en) 1996-03-14
CN1158085A (zh) 1997-08-27
RU2003115093A (ru) 2004-12-10
AU3460495A (en) 1996-03-27
NO970946L (no) 1997-04-28
NO970946D0 (no) 1997-02-28
DE69532285T2 (de) 2004-09-23
HK1006108A1 (en) 1999-02-12
FI970865A (fi) 1997-03-14
FI970865A0 (fi) 1997-02-28
CN1213753C (zh) 2005-08-10
JPH10505087A (ja) 1998-05-19
KR970705390A (ko) 1997-10-09
TW449474B (en) 2001-08-11
DE69532285D1 (de) 2004-01-22
ES2211916T3 (es) 2004-07-16
EP0778770A1 (en) 1997-06-18
CZ60697A3 (cs) 1998-02-18
WO1996007412A1 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
AU4078897A (en) Anticonvulsant containing composition for treating neuropathic pain
EP0938305B8 (en) Method of alleviating pain by means of combining tramadol with an nmda antagonist
AU6686596A (en) Pain-alleviating drug composition and method for alleviating pain
HK1006108A1 (en) Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
MXPA02007690A (es) Composiciones de liberacion controlada que contienen agonista y antiagonista de opioide.
AU2636797A (en) Fast disintegrating oral dosage form
NZ319531A (en) An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
GEP20022784B (en) Celecoxib Composition
IL115871A0 (en) A pharmaceutical composition containing a melt-extruded blend of components and a method for the preparation thereof
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
NO20053104D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
AU3984597A (en) Formulation of 5-ht agonists
CA2244209A1 (en) Improved concentrated injection and infusion solutions for intravenous administration
MY119403A (en) Novel compounds with analgesic effect.
NZ235877A (en) Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
SI1572167T1 (sl) Transdermalni buprenorfinski dozirni reĹľim za analgezijo
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
DE59504270D1 (de) Retardtablette mit einem gehalt an diclofenac-na
PL312198A1 (en) Application of procaine in obtaining a pharmaceutical preparation of analgesic activity with minimum motorial blocking effect
KR940701249A (ko) 진통제
CA2400578A1 (en) Controlled-release compositions containing opioid agonist and antagonist
HUT72329A (en) Application of riluzole as a radiorestorer
MX9804797A (es) Nuevos compuestos con efecto analgesico.
MX9804798A (es) Nuevos compuestos con efecto analgesico.